These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 16467112

  • 1. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [Abstract] [Full Text] [Related]

  • 2. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL.
    Clin Cancer Res; 2003 Oct 01; 9(12):4606-13. PubMed ID: 14555536
    [Abstract] [Full Text] [Related]

  • 3. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
    Hultin TA, Filla MS, McCormick DL.
    Drug Metab Dispos; 1990 Oct 01; 18(2):175-9. PubMed ID: 1971569
    [Abstract] [Full Text] [Related]

  • 4. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U.
    Cancer Res; 1993 Dec 15; 53(24):6036-41. PubMed ID: 8261419
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M, Bocca P, Chiesa V, Decensi A, Pistoia V, Raffaghello L, Rozzo C, Montaldo PG.
    Cancer Res; 1995 Feb 15; 55(4):853-61. PubMed ID: 7850799
    [Abstract] [Full Text] [Related]

  • 6. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F.
    Cancer Res; 2006 Mar 15; 66(6):3238-47. PubMed ID: 16540676
    [Abstract] [Full Text] [Related]

  • 7. Retinoids and skin: microarrays shed new light on chemopreventive action of all-trans retinoic acid.
    Cheepala SB, Syed Z, Trutschl M, Cvek U, Clifford JL.
    Mol Carcinog; 2007 Aug 15; 46(8):634-9. PubMed ID: 17538947
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E, Giannì M, Fratelli M, Barzago MM, Raska I, Diomede L, Kurosaki M, Pisano C, Carminati P, Merlini L, Dallavalle S, Tavecchio M, Rochette-Egly C, Terao M, Garattini E.
    Mol Pharmacol; 2006 Sep 15; 70(3):909-24. PubMed ID: 16788091
    [Abstract] [Full Text] [Related]

  • 9. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS, Shao ZM, Li XS, Ordonez JV, Conley BA, Wu S, Dawson MI, Han QX, Chao WR, Quick T.
    Carcinogenesis; 1995 Oct 15; 16(10):2477-86. PubMed ID: 7586155
    [Abstract] [Full Text] [Related]

  • 10. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
    Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M.
    Cancer Res; 1989 Nov 01; 49(21):6149-52. PubMed ID: 2529028
    [Abstract] [Full Text] [Related]

  • 11. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
    Kabbout M, Hatoum A, Abou-Lteif G, Chakroun I, Homaidan FR, Darwiche N.
    Mol Carcinog; 2004 May 01; 40(1):12-23. PubMed ID: 15108326
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells.
    Shan D, Gopal AK, Press OW.
    Clin Cancer Res; 2001 Aug 01; 7(8):2490-5. PubMed ID: 11489831
    [Abstract] [Full Text] [Related]

  • 13. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F.
    Oncogene; 2007 Jun 07; 26(27):3952-62. PubMed ID: 17213814
    [Abstract] [Full Text] [Related]

  • 14. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis.
    Syed Z, Cheepala SB, Gill JN, Stein J, Nathan C, Digiovanni J, Batra V, Adegboyega P, Kleiner HE, Clifford JL.
    Cancer Prev Res (Phila); 2009 Oct 07; 2(10):903-11. PubMed ID: 19789299
    [Abstract] [Full Text] [Related]

  • 15. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M, Wharton JT, Wang J, McWatters A, Auersperg N, Gershenson D, Bast R, Zou C.
    Gynecol Oncol; 2005 Aug 07; 98(2):182-92. PubMed ID: 15907982
    [Abstract] [Full Text] [Related]

  • 16. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A.
    Anticancer Res; 2005 Aug 07; 25(3B):1945-51. PubMed ID: 16158929
    [Abstract] [Full Text] [Related]

  • 17. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.
    Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM.
    Cancer Res; 1999 Jan 01; 59(1):14-8. PubMed ID: 9892176
    [Abstract] [Full Text] [Related]

  • 18. beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice.
    Ponnamperuma RM, Shimizu Y, Kirchhof SM, De Luca LM.
    Nutr Cancer; 2000 Jan 01; 37(1):82-8. PubMed ID: 10965524
    [Abstract] [Full Text] [Related]

  • 19. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM, Plante RK, Visconti V, Lau CY.
    Cancer Res; 1996 Mar 01; 56(5):1056-62. PubMed ID: 8640761
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis and restriction of G(1)/S cell cycle by fenretinide in Burkitt's lymphoma mutu I cell line accessed with bcl-6 down-regulation.
    Hsieh T, Wu JM.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1295-301. PubMed ID: 11027625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.